drugset / Trial / NCT01761825

The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome

NCT01761825

Phase 2 Unknown 20 enrolled Tel-Aviv Sourasky Medical Center
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Ivabradine is an effective treatment for postural tachycardia syndrome.

Timeline

Start
2012-12
Primary completion
2013-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivabradine Small molecule 10 mg